A Randomized, Double-Blind, Parallel, Multi-Center, Phase 2 Clinical Trial to Determine the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
A Randomized, Double-Blind, Parallel, Multi-Center, Phase 2 Clinical Trial to Determine the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee
The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.
Osteoarthritis of the knee
Inclusion Criteria:
Exclusion Criteria:
hjlee@addpharma.co.kr+82318915604